Trial Outcomes & Findings for Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere (NCT NCT06817785)

NCT ID: NCT06817785

Last Updated: 2026-08-31

Results Overview

The primary outcome of this study is lens comfort immediately after lens application on a scale of 0-100 (0= worst, 100=best).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

45 participants

Primary outcome timeframe

Immediately after lens application

Results posted on

2026-08-31

Participant Flow

Forty Five participants were screened. All the participants who were eligible in the study were included in the analysis. (n=45)

Participant milestones

Participant milestones
Measure
Lens 2 (Somofilcon A)
All participants wore lens 2 for 15 minutes (Period 2). Lens 2 (somofilcon A): 15 minutes of daily wear
Lens 1 (Ocufilcon D)
All participants wore lens 1 for 15 minutes (Period 1). Lens 1 (ocufilcon D): 15 minutes of daily wear
Lens 1 (15 minutes)
STARTED
0
45
Lens 1 (15 minutes)
COMPLETED
0
45
Lens 1 (15 minutes)
NOT COMPLETED
0
0
Lens 2 (15 minutes)
STARTED
45
0
Lens 2 (15 minutes)
COMPLETED
45
0
Lens 2 (15 minutes)
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Study Participant
n=45 Participants
Includes all study participants
Age, Continuous
30.0 years
STANDARD_DEVIATION 10.8 • n=45 Participants
Sex: Female, Male
Female
34 Participants
n=45 Participants
Sex: Female, Male
Male
11 Participants
n=45 Participants

PRIMARY outcome

Timeframe: Immediately after lens application

Population: Overall number of participants analyzed

The primary outcome of this study is lens comfort immediately after lens application on a scale of 0-100 (0= worst, 100=best).

Outcome measures

Outcome measures
Measure
Lens 1 (Ocufilcon D)
n=45 Participants
All participants wore lens 1 for 15 minutes (Period 1). Lens 1 (ocufilcon D): 15 minutes of daily wear
Lens 2 (Somofilcon A)
n=45 Participants
All participants wore lens 2 for 15 minutes (Period 2). Lens 2 (somofilcon A): 15 minutes of daily wear
Lens Comfort
88 Units on scale
Standard Deviation 14
93 Units on scale
Standard Deviation 8

Adverse Events

Lens 1 (Ocufilcon D)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Lens 2 (Somofilcon A)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jose Vega

CooperVision Inernational LTD

Phone: 9256213761

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place